Sélection de la langue

Search

Sommaire du brevet 1202193 

Énoncé de désistement de responsabilité concernant l'information provenant de tiers

Une partie des informations de ce site Web a été fournie par des sources externes. Le gouvernement du Canada n'assume aucune responsabilité concernant la précision, l'actualité ou la fiabilité des informations fournies par les sources externes. Les utilisateurs qui désirent employer cette information devraient consulter directement la source des informations. Le contenu fourni par les sources externes n'est pas assujetti aux exigences sur les langues officielles, la protection des renseignements personnels et l'accessibilité.

Disponibilité de l'Abrégé et des Revendications

L'apparition de différences dans le texte et l'image des Revendications et de l'Abrégé dépend du moment auquel le document est publié. Les textes des Revendications et de l'Abrégé sont affichés :

  • lorsque la demande peut être examinée par le public;
  • lorsque le brevet est émis (délivrance).
(12) Brevet: (11) CA 1202193
(21) Numéro de la demande: 1202193
(54) Titre français: UTILISATION DES ACIDES HALOACETIQUES A DES DOSES HOMEOPATIQUES, EN MEDECINE HUMAINE ET VETERINAIRE, DANS LES PRODUITS D'HYGIENE PERSONNEL ET LES PRODUITS PHYTOPHARMACEUTIQUES
(54) Titre anglais: USE OF HALOACETIC ACIDS AT HOMEOPATHIC DOSES, IN HUMAN AND VETERINARY MEDICINE, IN PERSONAL HYGIENE PRODUCTS AND IN PHYTOPHARMACEUTICAL PRODUCTS
Statut: Durée expirée - après l'octroi
Données bibliographiques
(51) Classification internationale des brevets (CIB):
  • A61K 31/19 (2006.01)
  • A61K 8/36 (2006.01)
  • A61Q 7/00 (2006.01)
  • A61Q 11/00 (2006.01)
  • A61Q 19/00 (2006.01)
  • C07C 53/16 (2006.01)
  • C07C 53/18 (2006.01)
(72) Inventeurs :
  • LE FOLL, JEAN (France)
(73) Titulaires :
  • LE FOLL, JEAN
(71) Demandeurs :
  • LE FOLL, JEAN
(74) Agent: MCCARTHY TETRAULT LLP
(74) Co-agent:
(45) Délivré: 1986-03-25
(22) Date de dépôt: 1982-03-04
Licence disponible: S.O.
Cédé au domaine public: S.O.
(25) Langue des documents déposés: Anglais

Traité de coopération en matière de brevets (PCT): Non

(30) Données de priorité de la demande:
Numéro de la demande Pays / territoire Date
81 04434 (France) 1981-03-05

Abrégés

Abrégé anglais


ABSTRACT
Compositions for pharmaceutical and personal hygiene
use containing halogenoacetic acid of the formula:
< IMG >
(in which R1, R2, R3 each represent a hydrogen or halogen
atom, one of the three at least representing a halogen) at
homeopathic doses.

Revendications

Note : Les revendications sont présentées dans la langue officielle dans laquelle elles ont été soumises.


-8-
THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. Compositions for homeopathic medicine comprising
one at least of the haloacetic acids of the formula:
< IMG >
in which R1, R2, R3 represent a hydrogen or
halogen atom, one at least of these radicals representing a
halogen atom and, when two or three of them each represent a
halogen, they can be identical or different,and a
physiologically acceptable vehicle, said acids being at
dilutions comprised within the range normally used in
homeopathy.
2. Compositions for homeopathic medicine according to
claim 1, in a parenterally administrable form as injectable
ampoules.
3. Compositions for homeopathic medicine according to
claim 1, in an orally administrable form.
4. Compositions for homeopathic medicine according to
claim 1, in a topically administrable form including creams,
pomades, lotions, aerosols, collyria or oils.
5. Personal hygiene products containing at least one
of the haloacetic acids recited in claim 1, at dilutions
equal to or higher than 4 CH.
6. Veterinary compositions according to claim 1, in
orally, parenterally or topically administrable form.
7. Phytopharmaceutical compositions according to
claim 1, in a form suitable for application to plants,
including a solution, suspension or aerosol.

-9-
8. Compositions according to claim 1, wherein the
haloacetic acid is present at a dilution in said vehicle of
from 4 CH to 30 CH.
9. A process of treating plants to effect improved
biological conditions therein, which comprises applying to
the plant a homeopathic dosage of a haloacetic acid of the
formula defined in claim 1.

Description

Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.


USE OF HALOACETIC ACXDS AT EIOMEOPATHIC DOSES, IN HUMAN AND
VETERINARY MEDICINE, IN PERSONAL HYGIENE PRODUCTS AND IN
PHYTOPHARMACEUTICAL PRODUCTS
_ ~ _
The invention relates to the use of homeopathic doses
in human and veterinary medicine, in phytopharmacy and in
personal hygiene products, of haloacetic acids of the
formulao
1 1
R2--C COOH ( I
R3
in which RL, R~l R3 each represent hydrogen or (F, Cl,
Br/ I) atom/ one at least of the radicals Rl, R2, R3
representing a halogen, and, when two or three of these
radicals represent a halogen, they may be identical or
different.
One of the important routes of cell metabolism is that
which is covered by the coenzyme A, which regulates, among
other things, the entrance of the acetate into the Krebs
cycle, the synthesis and degradation of lipid, the synthesis
of certain amino acids: alanine, valine, leucine, phospho-
amino-lipids, and chemicaL mediators such as acetylcholine.
The unaided acetate ion, as well as its higher
homologs, has difficulty undergoing cell metabolism due to a
resonance phenomenon:
C~3 - C / ~ C~13 - C
and must be activated by the CoA (work of Ingraham-Green)~
According to the invention it has been found that, if
an inductomeric effect is made to take part through one or
30 several halogens,: F-Cl-Br-I on CH3 - COOH, the molecule

L'33
is polarized and, thus activated, behavesS on the one hand,
like coenzyme A and, on the other hand, like a carrier of
the atom or atoms which have modified the resonance, when it
is used at homeopathic doses.
Furthermore, the inductomeric efEect can be modified by
playing, on the one hand, on the nature of the halogens
where the electronic charge fractions are established as
follows:
F = 0.27, Cl = 0.22, ~r = 0.20 1 = 0.16, and, on the other
hand, on their distribution, thus enabling the therapeutic
or metabolism regulating effects to be modiEied.
Clinical experiments on the products at homeopathic
doses according to the invention has shown that:
1) Substitution of 1, 2 or 3 hydrogen atoms of acetic
acid by 1, 2 or 3 atoms of Cl enables a generally beneficial
action to be produced on a fatigued organism.
2) The substitution of 1, 2 or 3 hydroqen atoms by 1, 2
or 3 atoms of F orients the therapeutic effect on to bone
lesions in general, dental lesions and the integuments
(nails, hair);
3) The substitution oE 1, 2 or 3 hydrogen atoms by 1, 2
or 3 Br atoms confers Oll the molecule a particular
protective action on the capillary circulation system;
4) The substitution of 1, 2 or 3 hydrogen atoms by 1, 2
or 3 I atoms causes stimulation of the thyroid and through
this regulation of the general metabolism, particularly at
the level of the skin, integuments and dental dystrophies.
The present invention provides pharmaceutical

compositions for homeopathic medicine, including
phytopharmacy, and personal hygiene products, characterized
in that they contain a haloacetic acid of above formula I,
at dilutions comprised within the range normally used in
homeophathy.
Homeopathy, as defined in Webster's New
Encyclopedic Dictionary, is "the system of treating disease
by administering in minute quantities drugs which would, if
given in larger doses to a healthy person, produce symptoms
similar to those of the disease, opposed to allopathy".
Homeopathic doses of medicine thus use minute quantities,
and are measured by number of C~, meaning Hahnemannil
Centesimal units, one CH unit meaning a dilution of l/lO0, 2
CH units meaning a dilution of l/10,000, 6 CH meaning
a dilution of l/10l2, etc~ Homeopathic doses are made by
means of a dilution step followed by a dynamization step.
The compositions useful in medicine are designed
either for the oral route and are then offered in the form
of granules or of drinkable solutions prepared according to
current methods in homeopathy, or for the parenteral route
in the form of injectable liquids in ampoules, or for the
local route and are prepared in the form of lotions, creams,
pomades, aerosols, collyria, suppositories, oils, etc. in a
pharmaceutical vehicle.
In personal hygiene products, the haloacetic acids
according to the invention are introduced at homeopathic
dilutions into dentifrices, mouth washes, shampoos, creams
and sun oils, in a physiologically suitable vehicle.
Below are given examples of use of the haloacetic
acids at homeopathic doses.
EXAMPLE 1
Phytopharmaceutical field.
A mimosa underwent the effect of the 78-79 winter
freeze and, through this fact, lost all-its leaves.
It was sprinkled with a solution containing ten

- 3a -
granules per liter of haloacetic acid at 5 CH according to
the invention.
Fifteen days later, the tree grew green again and
was again covered with leaves~ It is moreover still alive
at the date of this application.

~'0;~3;~
EXAMPLE 2
_eterinary medicine
A small mongrel dog found in the street was 14 years
old and had all the signs of advanced senescence: eczema,
thin hair, wrinkles and rasping of an old dog. It dragged
and had difficulty in moving.
It was made to take morning and night two granules of
haloacetic acid at 5CH.
The week had not ended when the eczema had entirely
disappeared, the hair had again become smooth and silky and
the animal ran.
At the date of this application the dog is more than 18
years old and, when it is tired, its master administers to
it the treatment that had saved it four years earlier, with
the same success.
EXAMPLE 3
Human medicine
The healing of a necrosis of the hip in less than four
months following a treatment by taking three granules of
haloacetic acid at 5CH is reported, plus one dose at 30CH
every eight days.
_XAMPIE 4
A patient received a burn from a hot iron (the cord was
connected to 220 V) on the palm of the right hand. The pain
was unbearable and phlyctena appeared.
An application of the following pomade:
haloacetic acid at 4CH + 5CH aa-10% excipient Q.S. was
made.

~h~Vf,J~L~
The application eased the pain in some moments and permitted
scar formation of the skin in 24 hours, the same time taken
for the patient to recover the use of the hand.
EXAMPLE 5
Numerous experiments carried out over 4 years on people
afflicted with sun burn showed that, even in the case of
severe burns, the painful sensations disappeared very
rapidly under the effect of light massage carried out with
an oil containing:
haloacetic acid at 5CH + 9CH + 15CH
EXAMPLE _
Capillary system
a) Alopecia
The use of a shampoo containing
the following formula stopped the fall of hair in a period
of 10 to 15 days in more than 80% of the cases:
haloacetic acid at 5CH
9CH aâ 10
15CH
excipient Q.S.
used three times per week.
b) Baldness
Where baldness is concerned, the
use twice daily of the following promade:
haloacetic acid at 5CH
7CH
9CH aa 20%
15 CH
excipient for pomade Q~S.

enabled the scalp to be restored. Subsequently there was
seen to appear, after a certain time and to varying
degrees, initially some fine fragile hair, which fell out,
regrew and became stronger and stronger. The density of
the new hair growth generally was a function of the age of
the subject and of his temperament.
F X fl M P
E~?~- 7
_
Odontostomatology
Buccal pathology is connected with more than 90
of cases concerning a dental condition and, consequently,
with the dental hygiene.
It is perhaps here that the qualities of this
halogenated formula as defined above, is manifested more
spectacularly. The general formula:
haloacetic acid at SCH
6CH ~a 20%
9CH
15CH
excipient Q.S.P. a tube of
dentifrice, gave spectacular results.
a) Dail~ dental hygiene
A study group of 50 people who regularly brushed
tn ~? "- 1S
morning and evening after ~e~s with a composition
according to this invention was compared to a control group
who regularly brushed with a common dentifrice. At the end
of a year of experiments it was found that the dental decay
of the study group was 47.5% less than that of the control
group.

b) Parodontolyses
In the case of parodontolyses, one of the symptoms,
gingival congestion with bleeding, disappears within a
period of one and two weeks, if brushing with the
S composition of this invention is carried out after each meal.
Moreover, in numerous cases, after a variable time,
restarting of alveolar osseous regenerescence with
consolidation of the dental mobility is seen to appear.
In the compositions according to the invention the
vehicle can be a customary physiologically acceptable
substance such as water, alcohol or an oil, and the vehicles
currently used in homeopathic compositions.
It is to be understood that the embodiments given above
are purely by way of illustrative example and that the
invention is not limited thereto.

Dessin représentatif

Désolé, le dessin représentatif concernant le document de brevet no 1202193 est introuvable.

États administratifs

2024-08-01 : Dans le cadre de la transition vers les Brevets de nouvelle génération (BNG), la base de données sur les brevets canadiens (BDBC) contient désormais un Historique d'événement plus détaillé, qui reproduit le Journal des événements de notre nouvelle solution interne.

Veuillez noter que les événements débutant par « Inactive : » se réfèrent à des événements qui ne sont plus utilisés dans notre nouvelle solution interne.

Pour une meilleure compréhension de l'état de la demande ou brevet qui figure sur cette page, la rubrique Mise en garde , et les descriptions de Brevet , Historique d'événement , Taxes périodiques et Historique des paiements devraient être consultées.

Historique d'événement

Description Date
Inactive : CIB désactivée 2011-07-26
Inactive : CIB de MCD 2006-03-11
Inactive : CIB de MCD 2006-03-11
Inactive : CIB de MCD 2006-03-11
Inactive : CIB de MCD 2006-03-11
Inactive : CIB de MCD 2006-03-11
Inactive : CIB dérivée en 1re pos. est < 2006-03-11
Inactive : CIB de MCD 2006-03-11
Inactive : Périmé (brevet sous l'ancienne loi) date de péremption possible la plus tardive 2003-03-25
Accordé par délivrance 1986-03-25

Historique d'abandonnement

Il n'y a pas d'historique d'abandonnement

Titulaires au dossier

Les titulaires actuels et antérieures au dossier sont affichés en ordre alphabétique.

Titulaires actuels au dossier
LE FOLL, JEAN
Titulaires antérieures au dossier
JEAN LE FOLL
Les propriétaires antérieurs qui ne figurent pas dans la liste des « Propriétaires au dossier » apparaîtront dans d'autres documents au dossier.
Documents

Pour visionner les fichiers sélectionnés, entrer le code reCAPTCHA :



Pour visualiser une image, cliquer sur un lien dans la colonne description du document. Pour télécharger l'image (les images), cliquer l'une ou plusieurs cases à cocher dans la première colonne et ensuite cliquer sur le bouton "Télécharger sélection en format PDF (archive Zip)" ou le bouton "Télécharger sélection (en un fichier PDF fusionné)".

Liste des documents de brevet publiés et non publiés sur la BDBC .

Si vous avez des difficultés à accéder au contenu, veuillez communiquer avec le Centre de services à la clientèle au 1-866-997-1936, ou envoyer un courriel au Centre de service à la clientèle de l'OPIC.


Description du
Document 
Date
(aaaa-mm-jj) 
Nombre de pages   Taille de l'image (Ko) 
Page couverture 1993-06-24 1 16
Abrégé 1993-06-24 1 8
Revendications 1993-06-24 2 40
Dessins 1993-06-24 1 7
Description 1993-06-24 8 208